KZA 0.00% 8.0¢ kazia therapeutics limited

Selling, page-139

  1. 21,797 Posts.
    lightbulb Created with Sketch. 890

    IMO

    Surely with all this attention imo many should be stepping up and buying up in droves -the science with their ears pinned back

    Re tested its all time low today - with so many collaborations and trials

    What do world class medical experts Heaton, Kelly and Hopper know ????


    ''Kazia has been pleased to observe very strong interest from clinicians and scientists in a range of other potential exploratory studies of GDC-0084 and remains in discussion regarding several other potential clinical collaborations.

    Publications

    Kazia is gratified to have been accepted for a 'trials in progress' poster presentation at the upcoming 23rdAnnual Scientific Meeting of the Society for Neuro-Oncology (SNO), which will be held inNew Orleans, LAon16-18 November 2018.

    Dana-Farber Cancer Institute (DFCI) inBoston, MAis establishing a phase II human trial of GDC-0084 in women with breast cancer brain metastases (BCBM), which is breast cancer that has spread to the brain. This study is expected to commence recruitment in early calendar 2019, pending approval by the Institutional Review Board at DFCI, and is not yet listed on clinicaltrials.gov.


    St Jude Children's Research Hospital inMemphis, TNhas commenced a phase I human trial of GDC-0084 in children with diffuse intrinsic pontine glioma (DIPG) and other diffuse midline gliomas. This study is currently recruiting and is listed on clinicaltrials.gov as NCT03696355.

    Recruitment to date has exceeded expectations, and the study remains on track to report initial data early in calendar 2019. It is listed on clinicaltrials.gov as NCT03522298. The study is also listed in the clinical trial finder section of the US National Brain Tumor Society website.''
    Last edited by Merchant2000: 19/06/19
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.